COVID-19 Vaccine Confidence Among Pregnant Women and Mothers
NCT04694664 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 18000
Last updated 2021-01-05
Summary
The purpose of this study is to assess the level of vaccine confidence and influencers among pregnant women and mothers of school-aged children during the COVID-19 pandemic.
Conditions
- Pregnancy Related
- Mothers
Interventions
- OTHER
-
This is an online survey with no intervention.
As this is an online survey about health and wellbeing, there is no intervention.
Sponsors & Collaborators
-
Harvard School of Public Health (HSPH)
collaborator OTHER -
Pregistry
lead INDUSTRY
Principal Investigators
-
Julia Wu, SD, MS · Harvard School of Public Health (HSPH)
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-10-01
- Primary Completion
- 2020-12-01
- Completion
- 2020-12-01
Countries
- United States
Study Locations
More Related Trials
-
Evaluation of the Acceptance of the Anti-COVID-19 Vaccine Offer Among Pregnant Women
NCT05729191 ·Status: COMPLETED
-
Vaccination Against COVID-19 in Pregnant and Lactating Women in Belgium
NCT05618548 ·Status: UNKNOWN
-
Influenza and Pertussis Vaccination Status of Women in Immediate Postpartum and Caregivers
NCT05234229 ·Status: COMPLETED
-
Evaluating Clinical Parameters of COVID-19 in Pregnancy
NCT04470583 ·Status: UNKNOWN
-
Assessing the Safety of Pregnancy In the CoRonavirus (COVID-19) pandEmic
NCT04388605 ·Status: ACTIVE_NOT_RECRUITING
-
Influenza Vaccine Effectiveness of a Quadrivalent Vaccine in Pregnant Women and Young Infants, 2019-2020
NCT04723771 ·Status: COMPLETED
-
COVID-19 Pregnancy Related Immunological, Clinical and Epidemiological Factors and Perinatal Outcomes
NCT04659759 ·Status: COMPLETED
-
FluLaval® Quadrivalent Pregnancy Registry
NCT02000466 ·Status: WITHDRAWN
-
COPE - COVID-19 in Pregnancy and Early Childhood
NCT04433364 ·Status: ACTIVE_NOT_RECRUITING
-
Prevalence and Impact of COVID-19 Infection in Pregnant Women, Fetuses and Newborns
NCT04355234 ·Status: COMPLETED ·Phase: NA
-
Demographics and Outcomes of COVID 19 in Pregnancy at a Community Based Hospital
NCT04385914 ·Status: UNKNOWN
-
Promotion of RSV Immunization Through Multiple Efforts
NCT06640868 ·Status: COMPLETED ·Phase: PHASE3
-
Maternal-foetal Transmission of SARS-Cov-2
NCT04395924 ·Status: COMPLETED
-
Group B Streptococcus: Attitudes to Immunisation in Pregnancy
NCT01982084 ·Status: COMPLETED
-
Characteristics of COVID-19 Infection Among PREGnant Women
NCT04398264 ·Status: COMPLETED
-
Increasing Influenza and Tdap Vaccination of Pregnant Women
NCT04444518 ·Status: COMPLETED ·Phase: NA
-
Assessment of Obstetric, Fetal and Neonatal Risks and Vertical SARS-CoV-2 Transmission During COVID-19 Pandemic
NCT04360811 ·Status: COMPLETED ·Phase: NA
-
MRSA Colonization in Peripartum Women and Their Offspring
NCT00336427 ·Status: COMPLETED
-
Transplacental Transmission of COVID-19
NCT05124574 ·Status: TERMINATED
-
Immune Response Induced by a Vaccine Against Group B Streptococcus and Safety in Pregnant Women and Their Offsprings
NCT01446289 ·Status: COMPLETED ·Phase: PHASE2
-
Maternal, Neonatal and Infant Outcomes at Kawempe National Referral Hospital
NCT04653948 ·Status: ACTIVE_NOT_RECRUITING
-
Assessing the Mother-to-infant Transmission Capabilities of COVID-19 Infection Among Pregnant Women in Ontario, Canada
NCT04913948 ·Status: COMPLETED
-
Assessing the Reliability of Self-Reported Hepatitis B Vaccination Status in Outpatients: Evaluation of Individuals Born in France and Consulting at the CeGIDD in Saint-Denis.
NCT06998992 ·Status: COMPLETED
-
Safety and Immunogenicity of a Group B Streptococcus Vaccine in Non Pregnant and Pregnant Women 18-40 Years of Age
NCT01193920 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Prophylactic Intrapartum Antibiotics and Immunological Markers for Postpartum Morbidity in HIV Positive Women
NCT00343317 ·Status: COMPLETED ·Phase: NA